MedDeviceGuide — IVD & Medical Device Knowledge Base

Compare IVD registration requirements across MENA, including Saudi SFDA, UAE EDE, Egypt EDA, Turkey TITCK, Israel AMAR, companion diagnostics, performance evidence, and point-of-care rules.

Compare MENA medical device clinical trial requirements, including Saudi SFDA, UAE, Egypt, Turkey, Israel, Qatar, authorization routes, evidence expectations, and multi-country trial planning.

Plan MENA medical device import, customs, and free zone strategy, including GCC tariffs, Saudi SABER and ZATCA, UAE EDE, Egypt EDA, Turkey TITCK, and duty optimization.

Analyze the 2026 MENA medical device market, including regional size, Saudi investment, GCC transactions, UAE and Egypt growth, digital health trends, and smart device demand.

Compare MENA medical device reimbursement systems, including Saudi CHI and NPHIES, UAE Daman, Turkey SGK, Israel Health Basket, Egypt UHIA, co-payments, and market access strategy.

Compare MENA post-market surveillance and vigilance rules for devices, including Saudi SFDA, UAE EDE, Turkey TITCK, Israel IRH, Egypt EDA, reporting timelines, PSURs, and shortage notices.

Medical device registration guide for Morocco, Algeria, and Tunisia, covering AMMPS, ANPP, DPM/ANMPS requirements, timelines, eCTD, serialization, and 2026 updates.

Guide to how Saudi Vision 2030 and UAE Operation 300bn affect medical device localization, procurement preferences, regulatory incentives, local content rules, and Gulf market entry.

UAE medical device registration guide under EDE, covering classification, fees, LAR requirements, DHA/DOH differences, and the post-MOHAP transition process.

Tracker of major medtech M&A deals in 2025 and 2026, including Abbott-Exact Sciences and Boston Scientific-Penumbra, with deal values, strategic rationale, and industry trends.

Data-driven analysis of cardiovascular medtech M&A, covering Stryker-Inari, Boston Scientific-Penumbra, Medtronic-CathWorks, PFA, structural heart innovation, and dealmaking trends in 2025-2026.

Register medical devices in Chile through ISP, including classification, GICONA submission, fees, timelines, documentation, and the 2026 decree expansion.

Guide to the European Commission MDR and IVDR simplification proposal, including software Rule 11, certificate validity, sandboxes, fees, timelines, and manufacturer impact.

How FTC enforcement is reshaping medtech M&A in 2025-2026, including Edwards/JenaValve, GTCR/Surmodics, HSR changes, and state mini-HSR laws.

Guide to medical device valuation in 2025-2026, including EBITDA and revenue multiples, pre-revenue methods, deal structures, CVRs, earn-outs, and diligence.

Guide to medical device startup funding in 2026, including typical raise sizes by stage, VC evaluation criteria, active subsectors, investor landscape, and fundraising positioning.

Analysis of 2025-2026 medtech divestitures and spinoffs, including BD-Waters, J&J DePuy Synthes, Siemens Healthineers, Medtronic MiniMed, and why large players are breaking up.

Review the 2026 medtech IPO and SPAC outlook, including Medline, Medtronic MiniMed, digital health listings, SPAC activity, public market conditions, and the pipeline.

Register medical devices in Peru through DIGEMID, covering risk classification, VUCE submission, documentation, holder duties, fees, timelines, and market access strategy.

Analysis of private equity in medtech, including the Hologic take-private, buy-and-build platforms, CDMO acquisitions, Medline IPO exit, and dry powder deployment.